FCMI

Foresite Capital Management IV Portfolio holdings

AUM $230M
1-Year Est. Return 64.1%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+64.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$183M
AUM Growth
+$58.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7
New
Increased
Reduced
Closed

Top Buys

1
+$18.9M
2
+$8.16M

Top Sells

1
+$26.8M
2
+$4.71M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHVS icon
1
Pharvaris
PHVS
$1.68B
$119M 65.29%
4,778,581
+368,000
CYTK icon
2
Cytokinetics
CYTK
$7.39B
$25.2M 13.79%
+458,295
MAZE
3
Maze Therapeutics
MAZE
$2.16B
$13.6M 7.42%
522,657
-1,589,262
LYEL icon
4
Lyell Immunopharma
LYEL
$477M
$13M 7.12%
800,399
XENE icon
5
Xenon Pharmaceuticals
XENE
$3.24B
$6.42M 3.52%
160,000
RLAY icon
6
Relay Therapeutics
RLAY
$1.71B
$5.22M 2.86%
1,000,000
KURA icon
7
Kura Oncology
KURA
$780M
– –
-816,882